JOIN OUR TEAM

Category: Healthcare

Beauty Retailing: U.S. Channel Analysis and Opportunities

Traditional Beauty Retailers: Take a lesson from alternate channels.

Alternate retail channels are white hot in the beauty business, having grown sales nearly $1 billion since 2005. Instead of trying to figure out how to compete, traditional bricks-and-mortar brands should take a page from the alternate channel playbook and leverage these new opportunities to reach customers at their new favorite place to shop: at home. (Read more…)

Know More »
The Markets for Excipients in the Middle East, Africa, and Southeast Asia

Excipient Blends: the new frontier in oral pharmaceutical applications.

Excipients are the unsung heroes of the oral solid-dosage-form (OSDF) pharmaceutical industry. Most consumers are completely unaware of the critical role excipients play in delivering the beneficial medicines millions rely on to fight diseases and stay healthy. Yet it is the fillers, binders, disintegrants, lubricants, and coatings that ensure the accurate, timed delivery of drugs required to safely maintain optimum active ingredient levels in our system.

With average growth forecast to exceed 4% through 2015, the excipients market for OSDF is expected to keep pace with the 6% growth on the pharmaceutical horizon… (Read more…)

Know More »
Rx-to-OTC Switch Forecasting Model

New Data Shows Plenty of Room for Innovators of All Sizes in OTC Market

The over-the-counter drug market is heating up as consumers turn increasingly toward self-medication in an effort to minimize out-of-pocket healthcare costs. With increasing competition from private-label products, blockbuster switches, and somewhat unconventional entries into the OTC drug business, new data reveals that while innovation doesn’t necessarily equate to superb business performance, there is plenty of

Know More »
Branded OTC Product Recalls

Branded OTC Product Recalls

The largest OTC company, Johnson & Johnson’s McNeil Consumer Healthcare, has been plagued by a series of product recalls recently and this has widespread repercussions to the OTC industry. The problems have ranged from moldy odors and contaminated shipping palettes, to concerns about levels of active ingredients in products, and concerns about product safety and

Know More »
Nonprescription Drugs Cost Structures

OTC Industry Looks to High-Growth OTC Switches to Fuel Industry Growth

Over the past few years, Rx-to-OTC switch products have emerged as a major growth driver in the U.S. OTC drug industry. While overall industry growth moderated to just 2.2% in 2008-2009, growth for Rx-to-OTC switches shot up by more than 12%. On the heels of numerous successful switches like Prevacid 24 Hour, Zegerid, Alli, and MiraLax, manufacturers have begun looking ahead at potential switch candidates much earlier in the Rx product life cycle. And with good reason: while the OTC market as a whole is expected to gain with just a CAGR of 2.6% over the next five years, future switches are set to explode by nearly 75%, adding more than $1.5 billion in absolute dollars to the OTC market.

Know More »
Future Growth of OTC Market

Bring your input to OTC Drugs: U.S. Competitor Cost Structures 2010

Kline is  pleased to announce that our research has begun for the OTC Drugs: U.S. Competitor Cost Structures 2010 study. Our lead research analyst, Mr. Prashant Sharma, is currently in touch with suppliers, manufacturers, packaging companies, ad agencies, financial analysts, and OTC marketers to understand how their cost structures have changed recently. We would like your

Know More »
Rx-to-OTC Switch Forecasting Model

Brands Make A Comeback; OTC Market Resilient During Recession

The U.S. OTC market is often a challenging market to make predictions about. There are so many instances where companies, brands, consumers, and even regulators buck trends that there are often reasons to look at things on a case-by case basis. However, when it came to predicting the impact the economic recession of 2008-2009 would

Know More »
Play Video
Play Video